PDCD1 and renal cell carcinoma: Interestingly, the finding that in renal cell carcinoma, obesity is associated with a diminished efficacy of PD-1 blockade, has been ascribed, at least in part, to the presence of constitutively elevated IL-1β levels which can also frequently found in the microenvironment of cHL [21, 22].